Furthermore, our data suggest FN1 as marker for progressive disease especially in papillary RCC.
Albuminuria has been considered a risk marker for progressive loss of renal function in type 2 diabetes with nephropathy, as well as a target for therapy (22).
Monocyte chemoattractant protein-1 (MCP1) is a potential marker for progressive renal disease because its expression and excretion are also regulated by bacterial endotoxins (13, 14).
Fibrinogen values over 3.5 g/L have been shown previously to be an independent marker for progressive cardiac events in diabetic patients [ 22].
SOD in seminal plasma of fresh boar semen was found to be a suitable predictive marker for progressive motility and viability following 3 days of storage.
If these findings are confirmed by a larger study, abnormal expression of FHIT protein in either biopsies (as in this study) or in cervical smears (Vecchione et al, 2001) could represent an additional marker for progressive potential in CIN1 lesions.
In summary, results from immunohistochemical analyses of tumours from two independent patient cohorts demonstrate that membranous PODXL expression is an independent marker for progressive disease and death in patients with urothelial bladder cancer.
We subjected 24 hpf G93Ros10-Sh1 embryos to a 4-day incubation in 1, 3, 5, 7, and 10μM riluzole and used DsRed fluorescence as a marker for progressive changes in the neuronal stress response.
In conclusion, it is suggested that (i) CSI is a novel human disease mechanism associated with lesion development and a potential target for therapeutic intervention in stroke; and that (ii) prolonged spreading suppressions of LF-VF are a novel 'functional marker' for progressive ischaemia.
The association between markers of fibrin degradation in patients with progressive breast cancer suggests that the D-dimer level is a clinically important marker for progression and points towards a relation between haemostasis and tumour progression.
